Angiotensin-converting enzyme inhibitor use and incident frailty in women aged 65 and older: Prospective findings from the women's health initiative observational study

Journal of the American Geriatrics Society

Volumn 57, Issue 2, 2009, Pages 297-303

  Gray, Shelly L ^a   Lacroix, Andrea Z ^b   Aragaki, Aaron K ^b   McDermott, Mary ^c   Cochrane, Barbara B ^a,b   Kooperberg, Charles L ^b   Murray, Anne M ^d   Rodriguez, Beatriz ^e   Black, Henry ^f   Woods, Nancy F ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d HENNEPIN COUNTY MEDICAL CENTER   (United States)

^e UNIVERSITY OF HAWAII   (United States)

^f RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ACE inhibitor use; Disability; Frailty; Women's Health Initiative

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG POTENCY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; PHYSICAL ACTIVITY; PHYSICAL CAPACITY; SELF REPORT; TREATMENT DURATION; TREATMENT OUTCOME; WALKING DIFFICULTY;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; FRAIL ELDERLY; HUMANS; PROSPECTIVE STUDIES;

EID: 58849125786     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2008.02121.x     Document Type: Article

References (30)

1. Bergman H, Ferrucci L, Guralnik J et al. Frailty: An emerging research and clinical paradigm - issues and controversies. J Gerontol A Biol Sci Med Sci 2007 62A : 731 737.
2. Fried LP, Tangen CM, Walston J et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001 56A : M146 M156.
3. Woods NF, LaCroix AZ, Gray SL et al. Frailty: Emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc 2005 53 : 1321 1330.
4. Penninx BW, Kritchevsky SB, Newman AB et al. Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc 2004 52 : 1105 1113.
5. Barzilay JI, Blaum C, Moore T et al. Insulin resistance and inflammation as precursors of frailty: The Cardiovascular Health Study. Arch Intern Med 2007 167 : 635 641.
6. Leng SX, Xue QL, Tian J et al. Inflammation and frailty in older women. J Am Geriatr Soc 2007 55 : 864 871.
7. Sumukadas D, Struthers AD, McMurdo ME. Sarcopenia - a potential target for angiotensin-converting enzyme inhibition? Gerontology 2006 52 : 237 242.
8. Gambassi G, Lapane KL, Sgadari A et al. Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. Arch Intern Med 2000 160 : 53 60.
9. Onder G, Penninx BWJH, Balkrishnan R et al. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: An observational study. Lancet 2002 359 : 926 930.
10. Di Bari M, van de Poll-Franse LV, Onder G et al. Antihypertensive medications and differences in muscle mass in older persons: The Health, Aging and Body Composition Study. J Am Geriatr Soc 2004 52 : 961 966.
11. Sumukadas D, Witham MD, Struthers AD et al. Effect of perindopril on physical function in elderly people with functional impairment: A randomized controlled trial. Can Med Assoc J 2007 177 : 867 874.
12. Peeters AC, Netea MG, Kullberg BJ et al. The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production. Immunology 1998 94 : 376 379.
13. Kranzhofer R, Schmidt J, Pfeiffer CAH et al. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999 19 : 1623 1629.
14. Walston J, Hadley EC, Ferrucci L et al. Research agenda for frailty in older adults: Toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 2006 54 : 991 1001.
15. Langer RD, White E, Lewis CE et al. The Women's Health Initiative Observational Study: Baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 2003 13 : S107 S121.
16. Manson JE, Greenland P, LaCroix AZ et al. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med 2002 347 : 716 725.
17. Anderson GL, Manson J, Wallace R et al. Implementation of the Women's Health Initiative Study design. Ann Epidemiol 2003 13 : S5 S17.
18. Ainsworth BE, Haskell WL, Leon AS et al. Compendium of physical activities: Classification of energy costs of human physical activities. Med Sci Sports Exerc 1993 25 : 71 80.
19. Curb JD, Mctiernan A, Heckbert SR et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol 2003 13 : S122 S128.
20. Burnam MA, Wells KB, Leake B et al. Development of a brief screening instrument for detecting depressive disorders. Med Care 1988 26 : 775 789.
21. Schellenbaum GD, Smith NL, Heckbert SR et al. Weight loss, muscle strength, and angiotensin-converting enzyme inhibitors in older adults with congestive heart failure or hypertension. J Am Geriatr Soc 2005 53 : 1996 2000.
22. Cao YJ, Mager DE, Simonsick EM et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther 2008 83 : 422 429.
23. Visser M, Pahor M, Taaffe DR et al. Relationship of interleukin-6 and tumor necrosis factor-{alpha} with muscle mass and muscle strength in elderly men and women: The Health ABC Study. J Gerontol A Biol Sci Med Sci 2002 57A : M326 M332.
24. Cahova M, Vavrinkova H, Tutterova M et al. Captopril enhanced insulin-stimulated glycogen synthesis in skeletal muscle but not fatty acid synthesis in adipose tissue of hereditary hypertriglyceridemic rats. Metabolism 2003 52 : 1406 1412.
25. Henriksen EJ, Jacob S. Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition. J Cell Physiol 2003 196 : 171 179.
26. Maggio M, Ceda GP, Lauretani F et al. Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age (the InCHIANTI study). Am J Cardiol 2006 97 : 1525 1529.
27. Onder G, Liperoti R, Russo A et al. Use of ACE inhibitors is associated with elevated levels of IGFBP-3 among hypertensive older adults: Results from the IlSIRENTE study. Eur J Clin Pharmacol 2007 63 : 389 395.
28. Cappola AR, Xue QL, Ferrucci L et al. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J Clin Endocrinol Metab 2003 88 : 2019 2025.
29. Onder G, Liperoti R, Russo A et al. Body mass index, free insulin-like growth factor I, and physical function among older adults: Results from the ilSIRENTE study. Am J Physiol Endocrinol Metab 2006 291 : E829 E834.
30. Kaplan RC, McGinn AP, Pollak MN et al. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults. J Am Geriatr Soc 2008 56 : 652 660.